Clinical Trial Update: Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes. [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the effects of linagliptin on renal endothelium function in patients with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Linagliptin (linagliptin)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Type 2-diabetes | Phase 3 | Status: COMPLETED